Articles published in Journal of AIDS & Clinical Research have been cited by esteemed scholars and scientists all around the world.
Journal of AIDS & Clinical Research has got h-index 29, which means every article in Journal of AIDS & Clinical Research has got 29 average citations.
Following are the list of articles that have cited the articles published in Journal of AIDS & Clinical Research.
| 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|
Year wise published articles |
66 | 61 | 32 | 29 | 31 |
Year wise citations received |
484 | 590 | 666 | 563 | 560 |
| Journal total citations count | 5061 |
| Journal impact factor | 2.8 |
| Journal 5 years impact factor | 10.46 |
| Journal cite score | 9.49 |
| Journal h-index | 29 |
| Journal h-index since 2018 | 21 |
Alba JE. Resultados de una intervencion de farmacovigilancia en pacientes con VIH/SIDA tratados con estavudina. Revista de Salúd Publica= Journal of Public Health. 2013 May 1;15(3):446. |
|
Chimukangara B, Varyani B, Shamu T, Mutsvangwa J, Manasa J, White E, Chimbetete C, Luethy R, Katzenstein D. HIV drug resistance testing among patients failing second line antiretroviral therapy. Comparison of in-house and commercial sequencing. Journal of Virological Methods. 2017 May 31;243:151-7. |
|
Chan WT, 陳穎芊. Comparative genotypic study of viral RNA and proviral DNA in HIV-1 patients. HKU Theses Online (HKUTO). 2015. |
|
Zaccarelli M, Santoro MM, Armenia D, Borghi V, Gennari W, Gori C, Forbici F, Bertoli A, Fabeni L, Giannetti A, Cicalini S. Genotypic resistance test in proviral DNA can identify resistance mutations never detected in historical genotypic test in patients with low level or undetectable HIV-RNA. Journal of Clinical Virology. 2016 Sep 30;82:94-100. |
|
Makadzange AT, Higgins-Biddle M, Chimukangara B, Birri R, Gordon M, Mahlanza T, McHugh G, van Dijk JH, Bwakura-Dangarembizi M, Ndung’u T, Masimirembwa C. Clinical, Virologic, Immunologic Outcomes and Emerging HIV Drug Resistance Patterns in Children and Adolescents in Public ART Care in Zimbabwe. PloS one. 2015 Dec 14;10(12):e0144057. |
|
Makadzange AT, Higgins-Biddle M, Chimukangara B, Birri R, Gordon M, Mahlanza T, McHugh G, van Dijk JH, Bwakura-Dangarembizi M, Ndung’u T, Masimirembwa C. Clinical, Virologic, Immunologic Outcomes and Emerging HIV Drug Resistance Patterns in Children and Adolescents in Public ART Care in Zimbabwe. PloS one. 2015 Dec 14;10(12):e0144057. |
|
Pessôa R, Watanabe JT, Calabria P, Felix AC, Loureiro P. Deep Sequencing of HIV-1 near Full-Length Proviral Genomes Identifies High Rates. |
|
Mzingwane ML, Mayaphi SH, Tiemessen CT, Richter K, Hunt G, Bowyer SM. Molecular characterisation and HIV drug resistance patterns of HIV-1 variants in plasma and peripheral blood mononuclear cells sample pairs. J AIDS Clin Res. 2016;7(562):2. |
|
Chimukangara B, Gwanzura L, Mitchell R, Katzenstein D, Masimirembwa C. Drug Resistance Mutations from Whole Blood Proviral DNA Among Patients on Antiretroviral Drugs in Zimbabwe. Current HIV research. 2014 Sep 1;12(5):309-16. |
|
Bernaud C, Khatchatourian L, Rodallec A, Hall N, Perre P, Morrier M, Pineau S, Jovelin T, André-Garnier E, Raffi F, Allavena C. Optimizing the virological success of tenofovir DF/FTC/rilpivirine in HIV-infected naive and virologically suppressed patients through strict clinical and virological selection. Infectious Diseases. 2016 Oct 2;48(10):754-9. |
|
Lübke N, Di Cristanziano V, Sierra S, Knops E, Schülter E, Jensen B, Oette M, Lengauer T, Kaiser R, Resina Study Group. Proviral DNA as a target for HIV-1 resistance analysis. Intervirology. 2015 Jun 27;58(3):184-9. |
|
Pessôa R, Watanabe JT, Calabria P, Felix AC, Loureiro P, Sabino EC, Busch MP, Sanabani SS. Deep sequencing of HIV-1 near full-length proviral genomes identifies high rates of BF1 recombinants including two novel circulating recombinant forms (CRF) 70_BF1 and a disseminating 71_BF1 among blood donors in Pernambuco, Brazil. PloS one. 2014 Nov 17;9(11):e112674. |
|
Derache A, Shin HS, Balamane M, White E, Israelski D, Klausner JD, Freeman AH, Katzenstein D. HIV drug resistance mutations in proviral DNA from a community treatment program. PloS one. 2015 Jan 30;10(1):e0117430. |
|
Tadele A, Shumey A, Hiruy N. Survival and predictors of mortality among adult patients on highly active antiretroviral therapy at Debre-markos referral hospital, North West Ethiopia; a retrospective cohort study. Journal of AIDS & Clinical Research. 2014. |
|
Koor GW. Genetic variation and differential expression of p21 (WAF1/CIP1) in the context of HIV-1 control (Doctoral dissertation). |
|
Syed IA, Sulaiman SA, Hassali MA, Syed SH, Shan LH, Lee CK. Factors associated with poor CD4 and viral load outcomes in patients with HIV/AIDS. Journal of medical virology. 2015 Oct 1. |
|
Herman MM. CD8+ T cells in HIV: The impact of responses to consensus HIV epitopes and their natural variants and implications for differential disease progression (Doctoral dissertation, University of Manitoba). |
|
Maina EK, Bonney EY, Bukusi EA, Sedegah M, Lartey M, Ampofo WK. CD4+ T cell counts in initiation of antiretroviral therapy in HIV infected asymptomatic individuals; controversies and inconsistencies. Immunology letters. 2015 Dec 31;168(2):279-84. |
|
Maina EK, Abana CZ, Bukusi EA, Sedegah M, Lartey M, Ampofo WK. Plasma concentrations of transforming growth factor beta 1 in non-progressive HIV-1 infection correlates with markers of disease progression. Cytokine. 2016 May 31;81:109-16. |
|
Chevigne A, Delhalle S, Counson M, Beaupain N, Rybicki A, Verschueren C, Staub T, Schmit JC, Seguin-Devaux C, Deroo S. Isolation of an HIV-1 neutralizing peptide mimicking the CXCR4 and CCR5 surface from the heavy-chain complementary determining region 3 repertoire of a viremic controller. Aids. 2016 Jan 28;30(3):377-82. |
|
Journal of AIDS & Clinical Research received 5061 citations as per Google Scholar report
Spanish 
Chinese 
Russian 
German 
French 
Japanese 
Portuguese 
Hindi 